98%
921
2 minutes
20
High-performing n-type organic electrochemical transistors (OECTs), crucial for integrated circuits in wearable bioelectronics, demand organic mixed ion-electron conductors (OMIECs) that exhibit efficient mixed conduction and biological functionality for practical applications. However, the development of self-healing OMIECs has not yet been achieved due to the lack of suitable synthetic strategies. Here, we present a design concept through incorporating dynamic cross-linked hydrogen-bonded in the polymer backbone for the first demonstration of self-healing polymeric mixed conductors, enabling high-performing OECTs and high gain, self-healing inverters. These devices exhibit a mixed conducting figure of merit µC* of 118 F cm V s, three times higher than the copolymer without hydrogen bond, along with simultaneously improved volumetric capacitance and electron mobility. These improvements are attributed to the unique microstructure created by hydrogen bond, which results in a closer π-π stacking distance within smaller crystalline domain sizes. Additionally, a cost-effective post-processing side chain removal method is proposed, which retains high performance in n-type OECTs. Remarkably, inverters based on the hydrogen-bonded terpolymer demonstrate high gain and self-healing capabilities through solvent vapor exposure and annealing treatment. Insights from these terpolymers emphasize the use of dynamic hydrogen bonds in the conjugated backbone to enhance performance and enable self-healing high-gain inverters, advancing wearable bioelectronics for practical applications.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/anie.202505011 | DOI Listing |
Ann Palliat Med
September 2025
Department of Psycho-Oncology, National Cancer Center Hospital, Tokyo, Japan.
Background: Delirium derived from dementia with Lewy bodies (DLB), and the risk of drug hypersensitivity derived from DLB is not well recognized in oncology. To avoid severe side effects caused by antipsychotics, these risks need to be carefully considered by health care providers involved in cancer treatment. The objective of this study is to report the presence of DLB-derived delirium, which is often mixed with ordinary delirium, and its associated hidden risk in cancer treatment.
View Article and Find Full Text PDFNurs Open
September 2025
Department of Nursing, Central Taiwan University of Science and Technology, Taichung City, Taiwan.
Aim: To explore nursing students' satisfaction levels of each specific item and perceptions under the unprecedented abrupt online clinical practicum during the COVID-19 pandemic.
Design: A mixed-method design comprises a questionnaire and qualitative content analysis.
Methods: The study used purposive sampling using data from nursing students in grade 3 of a 4-year bachelor RN programme at a technological university in the north of Taiwan, compiled from May 2021 to June 2021 using an online questionnaire.
BMC Health Serv Res
September 2025
Center for Health Services Research, Brandenburg Medical School Theodor Fontane, Seebad 82/83, Rüdersdorf, 15562, Germany.
Background: Hypertension remains a critical public health issue in Germany, affecting millions of individuals. Mobile health applications (mHealth apps) offer promising solutions for improving patient outcomes and adherence in hypertension management. Despite their advantages in healthcare, the adoption of mHealth apps by general practitioners (GPs) in Germany remains limited to date.
View Article and Find Full Text PDFJ Behav Health Serv Res
September 2025
Adolescent Behavioral Health Research Program, Indiana University School of Medicine, Indianapolis, IN, USA.
Evidence-based practices (EBPs) are most effective when they are delivered with a high degree of fidelity, or as they are intended to be delivered. Because clinicians often deviate from fidelity, it is important to monitor EBP fidelity over time to guide corrective actions. However, little is known about current fidelity monitoring practices in community behavioral health care.
View Article and Find Full Text PDFObes Surg
September 2025
Clinique Mutualiste de Pessac, Pessac, France.
Background: Preoperative treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) before bariatric surgery has not been studied. Therefore, we investigated the impact of neoadjuvant treatment with GLP-1 RAs on weight loss and postoperative outcomes in patients who underwent sleeve gastrectomy for severe obesity.
Method: A retrospective single-center study was conducted between January 2022 and December 2023.